The mission of Neuralink is to create a generalized brain interface to restore autonomy to a patient with unmet needs today, and to unlock human potential tomorrow.
A company backed by Elon Musk, Neuralink, has gained FDA approval to launch its first-in-human clinical study. The company stated on Twitter that it is the result of the Neuralink team working closely with the US Food and Drug Administration (FDA) and represents the first step that one day will allow the technology to help many people.
The mission of Neuralink is to create a generalized brain interface to restore autonomy to a patient with unmet needs today, and to unlock human potential tomorrow. The company says its brain-computer interfaces have the potential to change lives for the better and wants to bring that technology from the lab to the homes of patients in need. Neuralink is one step closer to doing so with its recent FDA approval, giving the company the ability to move from testing on animals to testing on human patients.
